VAERS reports by lot

GSK DTaP/Tdap lot 3RE73: VAERS reports

23 VAERS reports list lot 3RE73 as a GSK DTaP/Tdap vaccine, received between 2024-10-03 and 2025-12-22. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
0%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)528%
Neurological317%
Dermatological (non-injection-site)317%
Injection-site / Local reaction317%
Allergic / Anaphylactic211%
Musculoskeletal211%

Where reports came from

U.S. state of the reporter, where given (top 10).

StateReports
Wisconsin8
Oregon3
Colorado3
Illinois2
California2
Michigan1
Louisiana1
Nevada1
Arizona1
Georgia1

Reports by month received

MonthReportsBar
2024-102
2024-1115
2025-021
2025-051
2025-062
2025-101
2025-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK DTaP/Tdap lots (A–Z): 3JS9E · 3KS4F · 3M9Y7 · 3RT93 · 42Y93 · 43JH7

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.